Latest filing published 11 Jun 2021 for Cumberland Pharmaceuticals INC, €2,706.
Filing timeline
BuySaleInsider track record
Jonathan Griggs: trading record in brief
Jonathan Griggs (board member) discloses dealings in Cumberland Pharmaceuticals Inc to SEC (Form 4). The record holds 13 filings, for trades running from 24 March 2011 to 17 March 2021.
Every open-market trade on record is a sale: 1 sale worth €50k. The rest of the record consists of 11 share grants and 1 option exercise.
The latest filing, published on 11 June 2021, reports a share grant of €2,706 in Cumberland Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan Griggs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$3.22100.0% of flowCommon StockSEC:0001209191-21-039933:0
- 1,000 shares@ US$3.5655.2% of flowCommon StockSEC:0001209191-20-024889:0
- 1,000 shares@ US$5.9846.6% of flowCommon StockSEC:0001209191-19-021027:0
- 1,000 shares@ US$6.707.1% of flowCommon StockSEC:0001209191-18-021474:0
- 8,000 shares@ US$6.9765.1% of flowCommon StockSEC:0001209191-17-037366:0
- 1,000 shares@ US$6.458.0% of flowCommon StockSEC:0001209191-17-026320:0
- 1,000 shares@ US$4.345.0% of flowCommon StockSEC:0001209191-16-113792:0
- 700 shares@ US$6.69Common stockSEC:0001209191-15-038058:0
- 1,000 shares0Common stockSEC:0001209191-11-019672:0
9 of 9 declarations
